SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Alteryx, Inc. (AYX) .
Criteria proven by this page:
- VALUE (100/100, Pass) — analyst target implies upside (+67.6%).
- Analyst consensus target $80.86 (+67.6% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 44/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
✗
HEALTH
17/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — AYX
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio3.53
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-2.52
Book Value / Share$0.00
Revenue / Share$13.67
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
Analyst Target$80.86 (+67.6%)
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2014 |
$-0.43 |
$37.98M |
$-20.33M |
-53.5% |
| 2015 |
$-0.46 |
$53.82M |
$-21.45M |
-39.9% |
| 2016 |
$-0.50 |
$85.79M |
$-24.26M |
-28.3% |
| 2017 |
$-0.33 |
$131.61M |
$-17.5M |
-13.3% |
| 2018 |
$0.43 |
$253.57M |
$28.02M |
11.1% |
| 2019 |
$0.40 |
$417.91M |
$27.14M |
6.5% |
| 2020 |
$-0.37 |
$495.31M |
$-24.37M |
-4.9% |
| 2021 |
$-2.67 |
$536.14M |
$-179.68M |
-33.5% |
| 2022 |
$-4.65 |
$855.35M |
$-318.5M |
-37.2% |
| 2023 |
$-2.52 |
$970M |
$-179M |
-18.5% |
